v
Search
Advanced

Publications > Journals > Gastroenterology & Hepatology Research> Article Full Text

  • OPEN ACCESS

Advances in the diagnosis of drug-induced liver injury

  • Zhao-Chun Chi1,*
 Author information 

Abstract

Drugs are used to prevent, diagnose, and treat diseases, as well as improve physiological function and health level. With the increasing number of drug types and the lack of formal drug methods, the incidence of adverse reactions to drugs is also rising. Drug-induced liver disease is so common that in addition to poor drug quality, irrational drug use is the main reason, including drug abuse, misuse, low medical quality, and knowledge level of patients and their families; in addition, social problems such as lack of scientific management, medical ethics, and medical staff. Therefore, it is imperative to strengthen drug management, improve drug safety, and reduce the incidence of adverse reactions. Here we it is introduce and elaborate the current situation and progress in the diagnosis of drug-induced liver disease in recent years, so as to build a learning platform for the prevention and treatment of drug-induced liver disease in China.

Keywords

drug induced liver injury, diagnostic criteria, gene assay, apoptosis index, glutamate dehydrogenase, HMGB 1, exon, gene assay

About this Article

Cite this article
Chi ZC. Advances in the diagnosis of drug-induced liver injury. Gastroenterol & Hepatol Res. 2021;3(3):14. doi: 10.53388/ghr2021-09-037.
Copy        Export to RIS        Export to EndNote
Article History
Received Revised Accepted Published
September 12, 2021
DOI http://dx.doi.org/10.53388/ghr2021-09-037
  • Gastroenterology & Hepatology Research
  • eISSN 2703-173X
Back to Top

Advances in the diagnosis of drug-induced liver injury

Zhao-Chun Chi
  • Reset Zoom
  • Download TIFF